Monthly Archives: November 2023

VivArt-X receives pre-seed funding for accelerating and developing a proof-of-concept

VivArt-X has successfully closed a pre-seed investment round of 660,000 euros, thanks to the support of Brabant Startup Fund, the Brabantse Ontwikkelings Maatschappij (BOM), TU/e Participation Holding (the Gate), and a group of informal investors. Obtaining this funding will allow them to advance their lead program to pre-clinical development, a significant step toward enhancing regenerative […]

Read More

Laura Rijns successfully defends PhD thesis cum laude!

We are proud to announce that on 10 November 2023, Laura Rijns successfully defended her PhD thesis cum laude! Her thesis is titled “Design rules to dynamically control supramolecular hydrogel-cell interactions”, and features innovative contributions to the field such as those described in her paper: “The Importance of Effective Ligand Concentration to Direct Epithelial Cell […]

Read More